CAPRICOR THERAPEUTICS INC. - COMMON STOCK

13,50

10-января-25 09:46:46

15 мин. задержка

Акции

-0,36

-2,60%

Сегодняшний диапазон

13,43 - 13,80

ISIN

N/A

Источник

NASDAQ

Capricor Therapeutics to Participate in BIO Digital 2021 Conference

10 июн 2021 09:15:00 Источник Nasdaq GlobeNewswire
Capricor To Present Preclinical Data for Exosome-mRNA Vaccine for SARS-CoV-2 at the International Society for Extracellular Vesicles (ISEV) Annual Meeting

18 май 2021 08:30:00 Источник Nasdaq GlobeNewswire
Capricor Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

13 май 2021 16:05:00 Источник Nasdaq GlobeNewswire
Capricor to Present at the American Society of Gene and Cell Therapy’s 24th Annual Meeting

12 май 2021 09:00:01 Источник Nasdaq GlobeNewswire
Capricor Therapeutics to Present First Quarter 2021 Financial Results and Recent Corporate Update on May 13

06 май 2021 08:30:02 Источник Nasdaq GlobeNewswire
Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio

29 апр 2021 08:00:01 Источник Nasdaq GlobeNewswire
Capricor Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

11 мар 2021 16:01:00 Источник Nasdaq GlobeNewswire
Capricor Therapeutics Announces New Advances in Exosome-Mediated mRNA Delivery Platform

09 мар 2021 09:15:00 Источник Nasdaq GlobeNewswire
Capricor Therapeutics to Present Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Update on March 11

04 мар 2021 09:00:01 Источник Nasdaq GlobeNewswire
Capricor Therapeutics Announces Development of Serology Test to Confirm Activity of SARS-CoV-2 Vaccines

01 фев 2021 09:15:00 Источник Nasdaq GlobeNewswire
Capricor Therapeutics Announces Publication Demonstrating Methods for Enhanced Potency of Cardiosphere-Derived Exosomes

19 янв 2021 09:15:00 Источник Nasdaq GlobeNewswire
Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications

12 янв 2021 09:05:00 Источник Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.